CHAPTER 24: DIABETES DRUGS Flashcards
Amylin
- what is it
- actions
hormone co secreted w insulin from pancreatic beta cells
ACTION: delays gastric emptying, dec postprandial (after meal) glucagon secretion, improve satiety
Pramlintide
- synthetic form of amylin
- SC before major meal
- combo with insulin and oral agents
Pramlintide: Adverse effects
nausea, vomiting, anorexia, hypoglycemia
CANNOT be mixed in same syringe with insulin
Incretin Mimetics/GLP-1 Agonists
- incretin effect
- how does gut regulate it
Incretin effect reduced in type 2 diabetes
- gut releases incretin hormones, GLP-1, and GIP, in response to a meal, which are responsible for insulin secretion
Incretin mimetics/GLP-1 receptor agonists: 2 drugs
exenatide and liraglutide
Incretin Mimetics: MOA and route
mimic incretin hormones (GLP-1 receptor agonists)
- polypeptides–> SC route before meals
Incretin Mimetics: Actions/effects
- improves glucose dep insulin secretion
- slow gastric emptying time
- reduce food intake by inc satiety
- dec postprandial glucagon secretion
- promote Beta cell proliferation—> post prand hyperglycemia is reduced, HbA1c dec, weight loss
Incretin Mimetics: adverse effects
GI: nausea, vomit, diarrhea, constipation
- pancreatitis
-thyroid C-cell tumor (only liraglutide)
Oral Agents
- 3 types of PTs that need oral agents
- PT w type 2 diabetes not controlled w diet
- PT who develop diabetes after age 40, had it for less than 5 yrs
- PT with long-standing disease need combo or oral agents to control hyperglycemia
DPP-4 Inhibitors
- name the drugs
- MOA
- Alogliptin, linagliptin, saxagliptin, sitagliptin
MOA: inhibit DPP-4 enzyme that inactivates incretin hormone (GLP-1)–> increases insulin release in response to meal
DDP-4 is what inactives GLP-1 and GIP
DPP-4 Inhibitors: adverse effects
- nasopharyngitis
- headache
- pancreatitis
- dose adjust for renal dysfunction (drug is heavily metab by liver) except linagliptin
DPP-4 Inhibitors: drug-drug interactions
Strong liver enzyme inhibitors (antivirus/bacterial drugs) may INCREASE levels of saxagliptin
Sulfonylureas
- names
- use
- glyburide, glipizide, glimepiride
- insulin secretagogues: they promote insulin release from the B cells of pancreas
Sulfonylureas: MOA
- stim insulin release from B cells of pancreas—> block ATP dep K+ channels—> depolarize, influx Ca2+, insulin exocytosis
- may REDUCE hepatic glucose production and INC peripheral insulin sensitivity
Sulfonylureas: Adverse Effects
- hyperinsulinemia and hypoglycemia (imbalanced levels gluc and insulin)
- weight gain
- Gi distress (nausea, vomit, anorexia)
Glyburide: minimal placenta transfer